@J well put. I suspect that CH will raise their target price as KRMD demonstrates their ability to execute. And the validity of their marketing strategy of partnering early and becoming a preferred partner continues to be validated. As for legal costs. KRMD is asking to be reimbursed for legal and court fees. I hope that the legal wrangling with EMED will end this quarter. And if not then in the first quarter next year? No one wins in this fight except lawyers.
News 
Market Data 
Discover 
